Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
D015068:17-Ketosteroids / Q000652:urine; D000172:Acromegaly / Q000139:chemically induced; D000328:Adult; D000368:Aged; D000941:Antigens; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D015068:17-Ketosteroids; D000941:Antigens; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D004295:Dihydroxyphenylalanine; D013006:Growth Hormone; D002784:Cholesterol; D013974:Thyroxine